|
GYS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.573800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.816800E-01 |
| Normal-vs-Stage2 |
6.003300E-03 |
| Normal-vs-Stage3 |
9.891400E-01 |
| Normal-vs-Stage4 |
7.699600E-01 |
| Stage1-vs-Stage2 |
1.964390E-03 |
| Stage1-vs-Stage3 |
8.220800E-01 |
| Stage1-vs-Stage4 |
6.238200E-01 |
| Stage2-vs-Stage3 |
4.558600E-03 |
| Stage2-vs-Stage4 |
1.001530E-02 |
| Stage3-vs-Stage4 |
7.734600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.943400E-01 |
| Normal-vs-AfricanAmerican |
1.080810E-01 |
| Normal-vs-Asian |
1.887410E-01 |
| Caucasian-vs-AfricanAmerican |
1.573810E-01 |
| Caucasian-vs-Asian |
1.044410E-01 |
| AfricanAmerican-vs-Asian |
1.267860E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.777600E-02 |
| Normal-vs-Female |
9.193600E-01 |
| Male-vs-Female |
1.650370E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.969200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.208000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.887700E-02 |
| Normal-vs-Age(81-100Yrs) |
5.433000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.648400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.245700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.941400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.460900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.846800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.240000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.342200E-01 |
| Classical-VS-Follicular |
1.54190000001275E-06 |
| Classical-VS-Other |
5.318000E-01 |
| Classical-VS-Normal |
6.147200E-01 |
| Tall-VS-Follicular |
2.045400E-04 |
| Tall-VS-Other |
2.429200E-01 |
| Tall-VS-Normal |
1.478570E-01 |
| Follicular-VS-Other |
3.120400E-01 |
| Follicular-VS-Normal |
6.06029999999924E-05 |
| Other-VS-Normal |
6.522200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.947500E-02 |
| Normal-vs-N1 |
6.240800E-03 |
| N0-vs-N1 |
1.79631999999152E-05 |
|
|
